MinervaX and Wacker Biotech Join Forces for Manufacturing of Prophylactic Vaccine Against Group B Streptococcus Read more
Nura Bio Closes Series A Financing with $68 Million in New Funds, Bringing Total Raised to $140+ Million Read more
Orbis Medicines and Vivtex Form Research & Exclusive Licensing Collaboration to Support Orbis Development of Next-Generation Orally Dosable ‘nCycles’ Read more
Blenrep (belantamab mafodotin) combinations in relapsed/refractory multiple myeloma accepted for regulatory review in Japan Read more
FDA approves Novartis Kisqali to reduce risk of recurrence in people with HR+/HER2- early breast cancer Read more
Zentalis Pharmaceuticals Announces FDA Has Lifted Partial Clinical Hold on Azenosertib Studies Read more
Sanofi shipping BEYFORTUS in US to help protect babies against RSV disease; new manufacturing line approved by FDA Read more
MaxCyte Signs Strategic Platform License with Kamau Therapeutics to Accelerate the Development of Cell Therapies for Genetic Diseases Read more
SOPHiA GENETICS and AstraZeneca Collaborate to Further Expand Global Access to Liquid Biopsy Testing Read more